DK1052989T3 - Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion - Google Patents

Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion

Info

Publication number
DK1052989T3
DK1052989T3 DK99901703T DK99901703T DK1052989T3 DK 1052989 T3 DK1052989 T3 DK 1052989T3 DK 99901703 T DK99901703 T DK 99901703T DK 99901703 T DK99901703 T DK 99901703T DK 1052989 T3 DK1052989 T3 DK 1052989T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
trifluoromethoxybenzothiazole
amino
dysfunction
Prior art date
Application number
DK99901703T
Other languages
English (en)
Inventor
Andrees Bohme
Alain Boireau
Thierry Canton
Assunta Imperato
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1052989T3 publication Critical patent/DK1052989T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK99901703T 1998-02-06 1999-02-03 Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion DK1052989T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9801402A FR2774592B1 (fr) 1998-02-06 1998-02-06 Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
PCT/FR1999/000230 WO1999039710A1 (fr) 1998-02-06 1999-02-03 Application du 2-amino-6- trifluoromethoxy- benzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet

Publications (1)

Publication Number Publication Date
DK1052989T3 true DK1052989T3 (da) 2003-11-17

Family

ID=9522673

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99901703T DK1052989T3 (da) 1998-02-06 1999-02-03 Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion

Country Status (18)

Country Link
US (1) US6245791B1 (da)
EP (1) EP1052989B1 (da)
JP (1) JP5127092B2 (da)
KR (1) KR100574378B1 (da)
AT (1) ATE245982T1 (da)
AU (1) AU761978B2 (da)
CA (1) CA2319686C (da)
DE (1) DE69909970T2 (da)
DK (1) DK1052989T3 (da)
EA (1) EA002676B1 (da)
ES (1) ES2199541T3 (da)
FR (1) FR2774592B1 (da)
IL (2) IL137608A0 (da)
NO (1) NO327819B1 (da)
NZ (1) NZ506124A (da)
PT (1) PT1052989E (da)
WO (1) WO1999039710A1 (da)
ZA (1) ZA99740B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872739B1 (en) * 1999-06-04 2005-03-29 Vereniging Voor Christelijk Wetenshappelikjk Onderwijs Use of riluzole for the treatment of multiple sclerosis
RS62915B1 (sr) * 2015-03-03 2022-03-31 Biohaven Therapeutics Ltd Prolekovi riluzola i njihova primena
EP3706739B1 (en) * 2017-11-12 2024-10-16 Biohaven Therapeutics Ltd. Use of riluzole prodrugs to treat ataxias
SG11202011187QA (en) * 2018-05-27 2020-12-30 Biohaven Pharm Holding Co Ltd Use of riluzole oral disintigrating tablets for treating diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0374041B1 (fr) * 1988-12-15 1992-06-17 Rhone-Poulenc Sante Médicaments à base de dérivés de la benzothiazolamine-2, dérivés et leur préparation
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
FR2726271B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole

Also Published As

Publication number Publication date
DE69909970D1 (de) 2003-09-04
AU2171199A (en) 1999-08-23
FR2774592B1 (fr) 2000-03-17
ES2199541T3 (es) 2004-02-16
AU761978B2 (en) 2003-06-12
NO20003785D0 (no) 2000-07-24
ATE245982T1 (de) 2003-08-15
NZ506124A (en) 2003-07-25
NO327819B1 (no) 2009-09-28
JP5127092B2 (ja) 2013-01-23
WO1999039710A1 (fr) 1999-08-12
EP1052989B1 (fr) 2003-07-30
US6245791B1 (en) 2001-06-12
IL137608A (en) 2006-09-05
PT1052989E (pt) 2003-12-31
ZA99740B (en) 1999-08-02
KR100574378B1 (ko) 2006-04-26
KR20010040671A (ko) 2001-05-15
CA2319686C (fr) 2009-06-23
EP1052989A1 (fr) 2000-11-22
IL137608A0 (en) 2001-07-24
EA002676B1 (ru) 2002-08-29
NO20003785L (no) 2000-07-24
CA2319686A1 (fr) 1999-08-12
JP2002502819A (ja) 2002-01-29
FR2774592A1 (fr) 1999-08-13
DE69909970T2 (de) 2004-05-27
EA200000816A1 (ru) 2001-02-26

Similar Documents

Publication Publication Date Title
DK1066269T3 (da) Trisubstituerede 1,3,5-triazinderivater til behandling af HIV-infektioner
DE60225341D1 (de) Neue 1,2,4-triazolverbindung
DK1131315T3 (da) Polyhydroxylerede heterocykliske derivater som antikoagulanter
PT1307455E (pt) Inibidores de adesao celular mediada por (alfa)l (beta)2
TW200508228A (en) Biaryl heterocyclic compounds and methods of making and using the same
WO2005021495A3 (en) Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
DK1644312T3 (da) Fremstilling af derivater af 1,3-diphenylprop-2-en-1-on
BR9915129A (pt) Antagonistas do receptor de crf e processos relacionados aos mesmos
DK1071422T3 (da) Kombinationer af riluzol og levodopa til behandling af parkinsons sygdom
ES2169242T3 (es) 2-amino-benzoxazinonas para el tratamiento de infecciones virales.
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
AR022321A1 (es) Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada
DK1052989T3 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
EP1642576A3 (en) Methods, kits and compositions for using pyrrole derivatives to combat anxiety
EP1565448A4 (en) PROCESS FOR THE PREPARATION OF 10H-DIBENZOçB, F] ç1,4] THIAZEPIN-11-ON
DK1282599T3 (da) Disulfidderivater, der er egnede til behandling af allergiske sygdomme
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
ATE323493T1 (de) Gesteuerte freisetzung von antidepressiva
BR0007395B1 (pt) compostos de s-nitrosotióis como agentes para o tratamento de disfunções circulatórias.
DK1553938T3 (da) Anvendelse af epothilonderivater til behandling af hyperparathyroidisme
SE9501773D0 (sv) New use
ES2185154T3 (es) Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia.
SV2001000202A (es) Uso de (-)-5-ceto-2-n,n-d1-n-propilamino-tetrahidrotetralina para el tratamiento del mal de parkinson